Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9NT9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,109
Award facts
- Contract value 100% obligated
- $20,109.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,109.36 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Dupixent 300 mg/2 mL syringes with a completion date of February 2, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is the company's Conshohocken, Pennsylvania location. Dupixent (dupilumab) is a biologic medication used to treat conditions such as moderate-to-severe eczema, asthma, and chronic rhinosinusitis. This delivery order represents a single task order under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order for Dupixent exemplifies the company's role in fulfilling specialized pharmaceutical requirements across the federal healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F9NT9?
SPE2DR26F9NT9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9NT9 worth?
The government has obligated $20,109 on SPE2DR26F9NT9.
Is contract SPE2DR26F9NT9 an order under another contract?
Yes. SPE2DR26F9NT9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NT9 competed?
The extent of competition for SPE2DR26F9NT9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award